Neurent Medical

Neurent Medical, founded in 2014 and based in Ireland, is a pioneering player in the Health Care and Medical Devices industries. The company's slogan, "Pioneering innovative treatments for chronic inflammatory sino-nasal diseases," truly reflects its mission. Neurent Medical targets and disrupts hyperactive autonomic nerves that drive the underlying inflammation, offering a breakthrough solution for chronic rhinitis with their NEUROMARK treatment. This gentle in-office procedure aims to alleviate the persistent symptoms of nasal congestion, nasal drainage, and other related issues that significantly impact patient quality of life. In its latest funding round in December 2024, Neurent Medical secured investment from Claret Capital, showcasing growing investor confidence in the company's innovative approach to treating chronic inflammatory sino-nasal diseases. These developments position Neurent Medical as a noteworthy player in the medical technology space, with the potential to make a substantial impact on patient care in the field of chronic rhinitis and related conditions.